Crossmark

Preventing and managing dimethyl fumarate-related adverse effects in patients with multiple sclerosis may improve adherence

Crossref DOI link: https://doi.org/10.1007/s40267-018-0545-8

Published Online: 2018-08-03

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Writers, Adis Medical
License Information

Text and Data Mining valid from 2018-08-03
More Information

Article History

First Online: 3 August 2018

Compliance with ethical standards

:

: The article was adapted fromDrug Safety2018;41(4):347–56 [] by employees of Adis/Springer, who are responsible for the article content and declare no conflicts of interest.

: The preparation of this review was not supported by any external funding.